(Q39132883)

9 September 2017

title

Viability inhibition effect of gambogic acid combined with cisplatin on osteosarcoma cells via mitochondria-independent apoptotic pathway (English)

1 reference

9 September 2017

0 references

1 reference

1 reference

1 reference

Wei Zhao

1

1 reference

9 September 2017

Chang-Cheng You

2

1 reference

9 September 2017

Jin-Peng Zhuang

3

1 reference

9 September 2017

Jia-Ning Zu

4

1 reference

9 September 2017

Zhi-Yong Chi

5

1 reference

9 September 2017

Gong-Ping Xu

6

1 reference

9 September 2017

Jing-Long Yan

7

1 reference

9 September 2017

publication date

30 June 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

382

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

243-252

1 reference

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

The therapy of osteogenic sarcoma: Current status and thoughts for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Sensitization of Osteosarcoma Cell Line SaOS-2 to Chemotherapy by Downregulating Survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

TNFalpha-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Mechanisms of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Cisplatin resistance associated with PARP hyperactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Recent advances in understanding the cell death pathways activated by anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Life and death by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1740-5

CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis

21 January 2018

1 reference

12 December 2020

Targeting apoptosis pathways in cancer therapy

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study

1 reference

12 December 2020

Apoptosis: basic concepts and potential significance in human cancer

1 reference

12 December 2020

Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest

1 reference

12 December 2020

Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).

1 reference

12 December 2020

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

12 December 2020

Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway

1 reference

12 December 2020

10.1007/S11010-013-1740-5

Identifiers

DOI

1 reference

release_5gde2lcibrceddt2ygmfbjdec4

9 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5gde2lcibrceddt2ygmfbjdec4

24 November 2022

mapped directly with Wikidata item

1 reference